여성 건강 소비재 시장 : 시장 기회, 성장 요인, 업계 동향 분석 및 예측(2025-2034년)

The Global Womens Health Consumer Products Market was valued at USD 42 billion in 2024 and is estimated to grow at a CAGR of 5% to reach USD 68.2 billion by 2034.

The valuation includes both prescription-based and over-the-counter women's health products sold through hospital pharmacies, independent pharmacies, drug stores, and digital retail platforms. Market growth is shaped by shifting demographics, rising focus on preventive care, increasing health literacy, and evolving regulatory frameworks that encourage wider product availability. The upward trend is further supported by rising incomes and urban development in emerging regions, particularly across the Asia Pacific, where demand for specialized and high-quality health solutions continues to strengthen. Market sizing reflects regional differences in pricing, access to care, and purchasing behaviors. North America and Europe demonstrate higher per-capita spending due to strong awareness levels and well-established healthcare systems, while markets in Latin America, the Middle East & Africa, and Asia Pacific are expanding rapidly as infrastructure improves and awareness broadens. Together, these dynamics contribute to consistent, long-term growth worldwide.

The feminine hygiene products segment held a 37% share in 2024 and is forecast to grow at a CAGR of 5.2% during 2025-2034. This category includes menstrual care and intimate hygiene items and remains dominant due to constant replenishment cycles and the essential nature of routine hygiene products. Advances in materials and design continue to emphasize safety, comfort, and environmentally mindful solutions for consumers.

The low-price women's health products segment accounted for a 50.75% share in 2024 and is expected to grow at a CAGR of 5.2%. This segment encompasses widely used personal health items, vitamins, supplements, and everyday hygiene products. It maintains its leading share because many of these goods are purchased frequently, and affordability remains a critical factor, particularly in developing economies and among cost-conscious consumers.

North America Womens Health Consumer Products Market captured 26.4% share in 2024 and is projected to grow at a CAGR of 5.2% through 2034. High spending levels, strong healthcare systems, and supportive regulatory environments contribute to the region's leadership position. The area remains a hub for women's health technology innovation, with more than 33% of global femtech ventures based there in 2024. Approximately 20% of these ventures focus on pregnancy and nursing solutions, making this segment one of the most significant contributors to regional growth.

Key companies active in the Womens Health Consumer Products Market include Abbott Laboratories, Amgen, Amway Global, Bayer, Blackmores, Ferring Pharmaceuticals, GNC Holdings, Herbalife Nutrition, Johnson & Johnson, Merck & Co., Nestle, Pfizer, Suntory Holdings, Teva Pharmaceutical Industries, and The Himalaya Drug Company. Leading companies are strengthening their Womens Health Consumer Products Market presence by expanding product portfolios across nutritional health, hormonal wellness, reproductive care, and daily hygiene categories. Many firms are investing in R&D to introduce science-backed formulations, clean-label ingredients, and personalized solutions that align with rising consumer interest in preventive health. Digital engagement strategies, including telehealth integration, mobile apps, and targeted online channels, are improving brand visibility and accessibility. Companies are also widening distribution through partnerships with pharmacies, e-commerce platforms, and healthcare providers to reach a broader customer base.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
• 1.3 Data collection methods
• 1.4 Data mining sources
  • 1.4.1 Global
  • 1.4.2 Regional/Country
• 1.5 Base estimates and calculations
  • 1.5.1 Base year calculation
  • 1.5.2 Key trends for market estimation
• 1.6 Primary research and validation
  • 1.6.1 Primary sources
• 1.7 Forecast model
• 1.8 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 Age group
  • 2.2.4 Price
  • 2.2.5 Distribution channel
• 2.3 CXO perspectives: strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factors affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of women’s health and chronic conditions
    • 3.2.1.2 Advancements in technology & digital health / femtech
    • 3.2.1.3 Increasing awareness and supportive policy/government initiatives
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stigma, cultural & access barriers
    • 3.2.2.2 Regulatory, research and clinical trial gaps
    • 3.2.2.3 Data privacy, fragmenting product categories, and cost pressures
  • 3.2.3 Opportunities
    • 3.2.3.1 Expansion of femtech and digital health solutions
    • 3.2.3.2 Rising demand for preventive and holistic wellness products
    • 3.2.3.3 Untapped markets in emerging economies and niche segments
• 3.3 Growth potential analysis
• 3.4 Future market trends
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Price trends
  • 3.6.1 By region
  • 3.6.2 By Product type
• 3.7 Regulatory landscape
  • 3.7.1 standards and compliance requirements
  • 3.7.2 Regional regulatory frameworks
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Consumer behavior analysis
  • 3.10.1 Purchasing patterns
  • 3.10.2 Preference analysis
  • 3.10.3 Regional variations in consumer behavior
  • 3.10.4 Impact of e-commerce on buying decisions

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 Latin America
    • 4.2.1.5 Middle East and Africa
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates & Forecast, By Product Type, 2021 - 2034 ($Bn, Thousand Units)

• 5.1 Key trends
• 5.2 Feminine hygiene products
  • 5.2.1 Sanitary napkins
  • 5.2.2 Tampons
  • 5.2.3 Menstrual cups
  • 5.2.4 Panty liners
  • 5.2.5 Others
• 5.3 Maternity & pregnancy care products
  • 5.3.1 Prenatal vitamins
  • 5.3.2 Maternity wear
  • 5.3.3 Stretch mark creams
  • 5.3.4 Pregnancy supplements
• 5.4 Sexual wellness products
  • 5.4.1 Contraceptives
  • 5.4.2 Lubricants
  • 5.4.3 Intimate health products
• 5.5 Nutritional & dietary supplements
• 5.6 Other personal care products (skincare, hair care, and wellness products)

Chapter 6 Market Estimates & Forecast, By Age Group 2021 - 2034 ($Bn, Thousand Units)

• 6.1 Key trends
• 6.2 Teenagers & young adults
• 6.3 Adults
• 6.4 Middle-aged & older women

Chapter 7 Market Estimates & Forecast, By Price, 2021 - 2034 ($Bn, Thousand Units)

• 7.1 Key trends
• 7.2 Low
• 7.3 Medium
• 7.4 High

Chapter 8 Market Estimates & Forecast, By Distribution channel, 2021 - 2034 ($Bn, Thousand Units)

• 8.1 Key trends
• 8.2 Online platforms
  • 8.2.1 E-commerce marketplaces (Amazon, Flipkart, etc.)
  • 8.2.2 Brand websites & subscription boxes
  • 8.2.3 Mobile apps for Women’s health products
• 8.3 Offline retail
  • 8.3.1 Supermarkets & hypermarkets
  • 8.3.2 Pharmacies & drugstores
  • 8.3.3 Specialty health & wellness stores

Chapter 9 Market Estimates & Forecast, By Region, 2021 - 2034 ($Bn, Thousand Units)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 UK
  • 9.3.2 Germany
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Russia
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 MEA
  • 9.6.1 UAE
  • 9.6.2 South Africa
  • 9.6.3 Saudi Arabia

Chapter 10 Company Profiles

• 10.1 Abbott Laboratories
• 10.2 Amgen
• 10.3 Amway Global
• 10.4 Bayer
• 10.5 Blackmores
• 10.6 Ferring Pharmaceuticals
• 10.7 GNC Holdings
• 10.8 Herbalife Nutrition
• 10.9 Johnson & Johnson
• 10.10 Merck & Co.
• 10.11 Nestle
• 10.12 Pfizer
• 10.13 Suntory Holdings
• 10.14 Teva Pharmaceutical Industries
• 10.15 The Himalaya Drug Company